Lives unaffected by cystic fibrosis

Clinical Trial Finder

Be a part of the movement transforming the future of cystic fibrosis treatment.

Clinical trials are listed below.

  • Restore CFTR FunctionCompleted with results Location: Multiple care centres across the US

    Study of VX-445 plus ivacaftor and tezacaftor in people with CF who have two copies of the F508 del CFTR mutation (Vertex VX17-445-103) , protocol number NCT03525548 VX17-445-103

    This study evaluated the effectiveness and safety of the CFTR modulator drug VX-445 (elexacaftor) in combination with ivacaftor and tezacaftor. This triple combination is known as Trikafta. This study was for people with CF ages 12 and older who have two copies of the F508del CFTR mutation and were already taking tezacaftor plus ivacaftor.

    • Age:

      12 years and older

    • Mutation(s):

      Two copies of F508del

    • FEV1% Predicted:

      40 - 90%

    • Number of Visits:

      7

    • Length of Participation:

      10 weeks

    Contact us about this clinical Trial >
  • Displaying results 201-201 (of 201)
     |<  <  12 - 13 - 14 - 15 - 16 - 17 - 18 - 19 - 20 - 21 >  >|